Progress update: Pharmacological treatment of Alzheimer’s disease

References

• AisenPSDavisKLBergJD2000A randomized controlled trial of prednisone in Alzheimer’s diseaseNeurology545889310680787
   PubMed Web of Science ®Google Scholar
• AisenPSSchaferKAGrundmanM2003Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trialJAMA28928192612783912
   PubMed Web of Science ®Google Scholar
• AlmeidaOPFlickerL2003Testosterone and dementia: too much ado about too little dataJ Br Menopause Soc91071014670195
   PubMedGoogle Scholar
• Anonymous2006NICE faces legal challenge over restriction on dementia drugsBMJ3331085
   Google Scholar
• AuriacombeSPereJJLoria-KanzaY2002Efficacy and safety of rivastigmine in patients with Alzheimer’s disease who failed to benefit from treatment with donepezilCurr Med Res Opin181293812094822
   PubMed Web of Science ®Google Scholar
• BalkEMRamanGTatsioniA2007Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trialsArch Intern Med167213017210874
   PubMed Web of Science ®Google Scholar
• BartorelliLGiraldiCSaccardoM2005Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer’s diseaseCurr Med Res Opin2118091816307702
   PubMed Web of Science ®Google Scholar
• BentSGoldbergHPadulaA2005Spontaneous bleeding associated with Ginkgo biloba – a case report and systematic review of the literatureJ Gen Intern Med206576116050865
   PubMed Web of Science ®Google Scholar
• BirksJ2006Cholinesterase inhibitors for Alzheimer’s diseaseCochrane Database Syst Rev1CD00559316437532
   PubMed Web of Science ®Google Scholar
• BirksJGrimley EvansJIakovidouV2000Rivastigmine for Alzheimer’s diseaseCochrane Database Syst Rev4CD001191
   Google Scholar
• BirksJGrinleyEVVan DongenM2002Ginkgo biloba for cognitive impairment and dementiaCochrane Database Syst Rev4CD00312012519586
   PubMedGoogle Scholar
• BirksJHarveyR2006Donepezil for dementia due to Alzheimer’s diseaseCochrane Database Syst Rev1CD00119016437430
   PubMed Web of Science ®Google Scholar
• BordierPGarrigueSBaroldSS2003Significance of syncope in patients with Alzheimer’s disease treated with cholinesterase inhibitorsEuropace54293114753643
   PubMed Web of Science ®Google Scholar
• BordierPLanusseSGarrigueS2005Causes of syncope in patients with Alzheimer’s disease treated with donepezilDrugs Aging226879416060718
   PubMed Web of Science ®Google Scholar
• BullockRConnollyC2002Switching cholinesterase inhibitor therapy in Alzheimer’s disease – donepezil to rivastigmine, is it worth it?Int J Geriatr Psychiatry17288911921158
   PubMed Web of Science ®Google Scholar
• BullockRTouchonJBergmanH2005Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer’s disease over a 2-year periodCurr Med Res Opin2113172716083542
   PubMed Web of Science ®Google Scholar
• BurnsAO’BrienJ2006on behalf of the BAP Dementia Consensus Group Clinical practice with anti-dementia drugs: a consensus statement from British Association for PsychopharmacologyJ Psychopharmacol207325517060346
   PubMed Web of Science ®Google Scholar
• CherrierMMMatsumotoAMAmoryJK2005Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairmentNeurology642063815985573
   PubMed Web of Science ®Google Scholar
• ChohanMOIqbalK2006From tau to toxicity: Emerging roles of NMDA receptor in Alzheimer’s diseaseJ Alzheimers Dis1081716988485
   PubMed Web of Science ®Google Scholar
• CleggABryantJNicholsonT2002Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer’s disease. A systematic reviewInt J Technol Assess Health Care1849750712391943
   PubMed Web of Science ®Google Scholar
• CosmanKMBoyleLLPorsteinssonAP2007Memantine in the treatment of mild-to-moderate Alzheimer’s diseaseExpert Opin Pharmacother82031417257090
   PubMed Web of Science ®Google Scholar
• CourtneyCFarrellDGrayR2004Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trialLancet36321051515220031
   PubMed Web of Science ®Google Scholar
• CreeleyCEWozniakDFNardiA2006Donepezil markedly potentiates memantine neurotoxicity in the adult rat brainNeurobiol Aging
   Web of Science ®Google Scholar
• DantoineTAuriacombeSSarazinM2006Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer’s disease who failed to benefit from previous cholinesterase inhibitor treatmentInt J Clin Pract601101816409439
   PubMed Web of Science ®Google Scholar
• DoodyRSGeldmacherDSGordonB2001Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer’s diseaseArch Neurol58427311255446
   PubMed Web of Science ®Google Scholar
• DoodyRSStevensJCBeckC2001Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology5611546611342679
   PubMed Web of Science ®Google Scholar
• DybiczSBKeohaneDJErwinWG2006Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysisAm J Geriatr Pharmacother41546016860262
   PubMedGoogle Scholar
• EmreM2002Switching cholinesterase inhibitors in patients with Alzheimer’s diseaseInt J Clin Pract Suppl127647212139369
   PubMedGoogle Scholar
• FarlowMRCummingsJL2007Effective pharmacologic management of Alzheimer’s diseaseAm J Med1203889717466645
   PubMed Web of Science ®Google Scholar
• FiruziOPraticòD2006Coxibs and Alzheimer’s disease: should they stay or should they go?Ann Neurol592192816402383
   PubMed Web of Science ®Google Scholar
• GauthierSEmreMFarlowMR2003Strategies for continued successful treatment of Alzheimer’s disease: switching cholinesterase inhibitorsCurr Med Res Opin197071414687441
   PubMed Web of Science ®Google Scholar
• GarrardJHarrisSEberlyLEMatiakA2003Variations in product choices of frequently purchased herbs: caveat emptorArch Intern Med1632290514581247
   PubMed Web of Science ®Google Scholar
• GillSSMamdaniMNaglieG2005A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugsArch Intern Med1658081315824303
   PubMedGoogle Scholar
• Gillette-GuyonnetSCortesFCantetC2005Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer’s disease: data from the French REAL.FR cohortJ Nutr Health Aging9697315791348
   PubMed Web of Science ®Google Scholar
• GoedertMSpillantiniMG2006A Century of Alzheimer’s DiseaseScience3147778117082447
   PubMed Web of Science ®Google Scholar
• GreenCPicotJLovemanE2005Modeling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer’s diseasePharmacoeconomics2312718216336020
   PubMed Web of Science ®Google Scholar
• GrossbergGTEdwardsKRZhaoQ2006Rationale for combination therapy with galantamine and memantine in Alzheimer’s diseaseJ Clin Pharmacol4617S26S16809811
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative Group2002MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet36072212114036
   PubMed Web of Science ®Google Scholar
• HendersonVWHogervorstE2004Testosterone and Alzheimer disease. Is it men’s turn now?Neurology62170114745046
   PubMed Web of Science ®Google Scholar
• HoganDBPattersonC2002Progress in clinical neurosciences – treatment of Alzheimer’s disease and other dementias – review and comparison of the cholinesterase inhibitorsCan J Neurol Sci293061412463485
   PubMed Web of Science ®Google Scholar
• HoganDBGoldlistBNaglieG2004Comparison studies of cholinesterase inhibitors for Alzheimer’s diseaseLancet Neurol3622615380159
   PubMed Web of Science ®Google Scholar
• HogervorstEYaffeKRichardsM2002Hormone replacement therapy to maintain cognitive function in women with dementiaCochrane Database Syst Rev3CD00379912137718
   PubMedGoogle Scholar
• ImbimboBP2004The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer’s diseaseExpert Opin Investig Drugs13146981
   PubMed Web of Science ®Google Scholar
• IoannidisJPA2006Indirect comparisons: the mesh and mess of clinical trialsLancet3681470217071265
   PubMed Web of Science ®Google Scholar
• KaduszkiewiczHZimmermannTBeck-BornholdtHP2005Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomised clinical trialsBMJ331321716081444
   PubMed Web of Science ®Google Scholar
• KanowskiSHoerrR2003Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trialPharmacopsychiatry3629730314663654
   PubMed Web of Science ®Google Scholar
• KogutSJEl-MaoucheDAbughoshSM2005Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognitionPharmacotherapy2517293516305292
   PubMed Web of Science ®Google Scholar
• KurzAVan BaelenB2004Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the Cochrane CollaborationDement Geriatr Cogn Disord182172615237280
   PubMed Web of Science ®Google Scholar
• LanctôtKLHerrmannNYauKK2003Efficacy and safety of cholinesterase inhibitors in Alzheimer’s disease: a meta-analysisCMAJ1695576412975222
   PubMed Web of Science ®Google Scholar
• LoyCSchneiderL2006Galantamine for Alzheimer’s disease and mild cognitive impairmentCochrane Database Syst Rev1D001747
   Web of Science ®Google Scholar
• LuCJTuneLE2003Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer diseaseAm J Geriatr Psychiatry114586112837675
   PubMed Web of Science ®Google Scholar
• MaloufMGrimleyEJAreosaSA2003Folic acid with or without vitamin B12 for cognition and dementiaCochrane Database Syst Rev4CD00451414584018
   PubMedGoogle Scholar
• MaloufRGrimley EvansJ2003The effect of vitamin B6 on cognitionCochrane Database Syst Rev4CD00439314584010
   PubMedGoogle Scholar
• MaloufRAreosaSA2003Vitamin B12 for cognitionCochrane Database Syst Rev3CD00432612918012
   PubMed Web of Science ®Google Scholar
• MazzaMCapuanoABriaPMazzaS2006Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo-controlled double-blind studyEur J Neurol13981516930364
   PubMed Web of Science ®Google Scholar
• McGeerPLSchulzerMMcGeerEG1996Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: A review of 17 epidemiologic studiesNeurology47425328757015
   PubMed Web of Science ®Google Scholar
• McShaneRAreosa SastreAMinakaranN2006Memantine for dementiaCochrane Database Syst Rev2CD00315416625572
   PubMed Web of Science ®Google Scholar
• MillerERPastor-BarriusoRDalaiD2005Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortalityAnn Intern Med142374615537682
   PubMed Web of Science ®Google Scholar
• MoffatSDZondermanABMetterEJ2004Free testosterone and risk for Alzheimer disease in older menNeurology621889314745052
   PubMed Web of Science ®Google Scholar
• MorrisCAAvornJ2003Internet marketing of herbal productsJAMA2901505913129992
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence2006NICE technology appraisal guidance 111Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease [online]Accessed January 15, 2007 URL: http://www.nice.org.uk/TA111
   Google Scholar
• NewbyVJKennyAGrantI2004Donepezil and cardiac syncope: case reportInt J Geriatr Psychiatry1911101215497193
   PubMed Web of Science ®Google Scholar
• PattersonCGauthierSBergmanH2001The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on DementiaCan J Neurol Sci28 Suppl 1S31611237309
   PubMed Web of Science ®Google Scholar
• PeskindERPotkinSGPomaraN2006Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trialAm J Geriatr Psychiatry147041516861375
   PubMed Web of Science ®Google Scholar
• PetersenRCThomasRGGrundmanM2005Vitamin E and done-pezil for the treatment of mild cognitive impairmentN Engl J Med35223798815829527
   PubMed Web of Science ®Google Scholar
• PrianoLGascoMRMauroA2006Transdermal treatment options for neurological disorders: impact on the elderlyDrugs Aging233577516823990
   PubMed Web of Science ®Google Scholar
• RamsdenMShinTMPikeCJ2003Androgens modulate neuronal vulnerability to kainite lesionNeuroscience122573814622899
   PubMed Web of Science ®Google Scholar
• ReinesSABlockGAMorrisJC2004Rofecoxib: no effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled studyNeurology62667114718699
   PubMed Web of Science ®Google Scholar
• RiepeMWAdlerGIbachB2006Adding memantine to rivastigmine therapy in patients with mild-to-moderate Alzheimer’s disease: results of a 12-week, open-label pilot studyPrim Care Companion J Clin Psychiatry82586317235381
   PubMedGoogle Scholar
• RitchieCWAmesDClaytonT2004Meta-analysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer diseaseAm J Geriatr Psychiatry123586915249273
   PubMed Web of Science ®Google Scholar
• RockwoodK2004Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer’s diseaseJournal of Neurology Neurosurgery and Psychiatry7567785
   PubMed Web of Science ®Google Scholar
• RogersJKirbyLCHempelmanSR1993Clinical trial of indomethacin in Alzheimer’s diseaseNeurology431609118351023
   PubMed Web of Science ®Google Scholar
• SadowskyCHFarlowMRAtkinsonL2005Switching from donepezil to rivastigmine is well tolerated: results of an open-label safety and tolerability studyPrim Care Companion J Clin Psychiatry743815841194
   PubMedGoogle Scholar
• SanoMErnestoCThomasRG1997A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s diseaseN Engl J Med3361216229110909
   PubMed Web of Science ®Google Scholar
• ScharfSManderAUgoniA1999A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s diseaseNeurology5319720110408559
   PubMed Web of Science ®Google Scholar
• SchmittFRyanMCooperG2007A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer’s diseaseExpert Opin Drug Metab Toxicol31354117269900
   PubMed Web of Science ®Google Scholar
• SchneiderLSDekoskySTFarlowMR2005A randomized, double-blind, placebo-controlled trial of two doses of ginkgo biloba extract in dementia of the Alzheimer’s typeCurr Alz Res254155
   PubMedGoogle Scholar
• SeshadriSBeiserASelhubJ2002Plasma homocysteine as a risk factor for dementia and Alzheimer’s diseaseN Engl J Med3464768311844848
   PubMed Web of Science ®Google Scholar
• ShepherdJBlauwGJMurphyMB2002Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialLancet36016233012457784
   PubMed Web of Science ®Google Scholar
• SimonsMSchwärzlerFLütjohannD2002Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: a 26-week randomized, placebo-controlled, double-blind trialAnn Neurol523465012205648
   PubMed Web of Science ®Google Scholar
• SparksDLSabbaghMNConnorDJ2005Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary resultsArch Neurol62753715883262
   PubMed Web of Science ®Google Scholar
• StahlSMMarkowitzJSGuttermanEM2003Co-use of donepezil and hypnotics among Alzheimer’s disease patients living in the communityJ Clin Psychiatry644667212716251
   PubMed Web of Science ®Google Scholar
• SuleymanTTevfikPAbdulkadirG2006Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezilEmerg Med J23641216858101
   PubMed Web of Science ®Google Scholar
• SummersWKMajovskiLVMarshGM1986Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer typeN Engl J Med315124152430180
   PubMed Web of Science ®Google Scholar
• TabetNBirksJGrimley EvansJ2000Vitamin E for Alzheimer’s diseaseCochrane Database Syst Rev4CD00285411034775
   PubMedGoogle Scholar
• TabetNFeldmanH2002Indomethacin for the treatment of Alzheimer’s disease patientsCochrane Database Syst Rev2CD00367312076498
   PubMedGoogle Scholar
• TanRSPuSJ2003A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer’s diseaseAging Male6131712809076
   PubMedGoogle Scholar
• TariotPNSolomonPRMorrisJC2000A 5-month, randomized, placebo-controlled trial of galantamine in ADNeurology5422697610881251
   PubMed Web of Science ®Google Scholar
• TariotPNFarlowMRGrossbergGT2004Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trialJAMA2913172414734594
   PubMed Web of Science ®Google Scholar
• TaylorAMHoehnsJDAndersonDM2002Fatal aspiration pneumonia during transition from donepezil to rivastigmineAnn Pharmacother361550312243604
   PubMed Web of Science ®Google Scholar
• ThalLJGrundmanMBergJ2003Idebenone treatment fails to slow cognitive decline in Alzheimer’s diseaseNeurology61149850214663031
   PubMed Web of Science ®Google Scholar
• ThompsonSLanctôtKLHerrmannN2004The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s diseaseExpert Opin Drug Saf34254015335298
   PubMedGoogle Scholar
• TrinhNHHoblynJMohantyS2003Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysisJAMA2892101612517232
   PubMed Web of Science ®Google Scholar
• van Dongenvan RossumEKesselsA2003Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trialJ Clin Epidemiol563677612767414
   PubMed Web of Science ®Google Scholar
• Van DyckCHSchmittFAOlinJT2006A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezilAm J Geriatr Psychiatry144283716670247
   PubMed Web of Science ®Google Scholar
• van GoolWAWeinsteinHCScheltensPK2001Effect of hydroxychloroquine on progression of dementia in early Alzheimer’s disease: an 18-month randomised, double-blind, placebo-controlled studyLancet3584556011513909
   PubMed Web of Science ®Google Scholar
• WaldemarGDuboisBEmreM2007Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guidelineEur J Neurol14e12617222085
   PubMed Web of Science ®Google Scholar
• WhiteheadAPerdomoCPrattRD2004Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer’s disease: a meta-analysis of individual patient data from randomised controlled trialsInt J Geriatr Psychiatry196243315254918
   PubMed Web of Science ®Google Scholar
• WilkinsonDGHoweI2005Switching from donepezil to galantamine: a double-blind study of two wash-out periodsInt J Geriatr Psychiatry204899115852437
   PubMed Web of Science ®Google Scholar
• WinbladBKilanderLErikssonS2006Donepezil in patients with severe Alzheimer’s disease: double-blind, parallel-group, placebo-controlled studyLancet36710576516581404
   PubMed Web of Science ®Google Scholar
• WinbladBJelicVKershawP2007Effects of statins on cognitive function in patients with Alzheimer’s disease in galantamine clinical trialsDrugs Aging24576117233547
   PubMed Web of Science ®Google Scholar
• WolfsonCOremusMShuklaV2002Donepezil and rivastigmine in the treatment of Alzheimer’s disease: a best-evidence synthesis of the published data on their efficacy and cost-effectivenessClin Ther248628612117079
   PubMed Web of Science ®Google Scholar
• WolfsonCPerraultAMorideY2002A case-control analysis of nonsteroidal anti-inflammatory drugs and Alzheimer’s disease: are they protective?Neuroepidemiology2181611901277
   PubMed Web of Science ®Google Scholar